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ABSTRACT 
The purpose of the current study was to investigate the potential anti-obesity activity of an enzymatic hydrolysate 
of velvet antler in inhibiting adipogenesis in 3T3-L1 cells and in high-fat diet (HFD)-fed obese mice. The enzy-
matic hydrolysate was prepared using the commercial food grade protease, Protamex. The velvet antler Protamex 
hydrolysate (VAPH) indicated profound inhibitory effects on adipogenesis dose-dependently by decreasing the 
accumulation of triglycerides and down-regulating expression levels of adipogenesis-related proteins C/EBPα, 
SREBP-1, and PPARγ. In a mouse model of HFD-induced obesity, oral administration of VAPH (100 and 
300 mg/kg for 13 weeks) significantly reduced the body weight gain that had resulted from the HFD. VAPH treat-
ment also lowered the serum glucose and triglyceride levels, while increasing the HDL-C level. Furthermore, the 
treatment greatly reduced hepatic lipid droplet accumulation as well as the size of adipocytes. Current findings 
demonstrate that VAPH has profound anti-obesity effects and could be an effective candidate for preventing obe-
sity and obesity-related chronic diseases. 
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INTRODUCTION 
Obesity is defined as gaining excessive 
body weight in the form of fat, and is a major 
risk factor for chronic human diseases, such 
as type 2 diabetes, hypertension, and cardio-
vascular disease (Xavier and Sunyer, 2002; 
Lee et al., 2005; Kong et al., 2009). With the 
incidence of obesity increasing worldwide, 
the condition has become a serious health is-
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sue. Obesity prevention and treatment are im-
portant for reducing the risk of obesity-de-
rived diseases. In recent years, there has been 
increasing awareness of the benefits of health 
foods from natural products and interest in 
discovering new phytochemical compounds 
for human use. Many studies have identified 
anti-obesity agents from natural products, es-
pecially from herbs and plants (Kong et al., 
2009; Popovich et al., 2010; Ko et al., 2013b; 
Mohamed et al., 2014). However, despite the 
discoveries of various bioactive components 
in animal tissues that can be used in the pre-
vention and treatment of many human dis-
eases (Chen et al., 2010; Ge et al., 2012; Kim 
et al., 2014; Lee et al., 2015), reports that doc-
ument the anti-obesity activity of health foods 
from animal sources are still relatively rare.  
Velvet antler is a typical traditional medi-
cine of animal origin that has been used for 
over 2000 years and is still recognized in 
pharmacopeias of Korea, China, and Japan. In 
places such as East Asia, New Zealand, Can-
ada, and USA, it is also used as a health food 
supplement and a nutraceutical to prevent dis-
eases, presumably through the actions of its 
diverse biological components (Sui et al., 
2014). Velvet antler is considered to have var-
ious pharmacological effects, including stim-
ulation of the immune system, and enhance-
ments of physical strength and sexual func-
tion (Kawtikwar et al., 2010; Gilbey and Pe-
rezgonzalez, 2012). A previous study has re-
ported improved lipid metabolism in rats ad-
ministered a water-soluble extract of velvet 
antler (Cui et al., 2008). However, the effects 
of velvet antler on obesity-related adipogene-
sis are unknown.  
 Therefore, the purpose of this study was 
to investigate the effects of an enzymatic hy-
drolysate of velvet antler on lipid accumula-
tion, adipocyte differentiation, and adipogen-
esis-related protein expression in 3T3-L1 
cells. Moreover, we examined the effect of 
the hydrolysate on obesity by evaluating sev-
eral related parameters and histology in high-
fat diet-fed obese mice.   
 
MATERIAL AND METHODS 
Chemicals 
Mouse 3T3-L1 preadipocytes were ob-
tained from the American Type Culture Col-
lection (ATCC, Rockville, MD, USA). Dul-
becco’s modified Eagle’s medium (DMEM), 
fetal bovine serum (FBS), bovine serum (BS), 
and penicillin–streptomycin (PS) were pur-
chased from Gibco BRL (Grand Island, NY, 
USA). Antibodies to peroxisome proliferator 
activated receptor gamma (PPARγ) and 
CCAAT/enhancer binding protein (C/EBPα) 
were obtained from Cell Signaling Technol-
ogy (Bedford, MA, USA). Antibodies to 
sterol regulatory element binding protein 1 
(SREBP-1) and glyceraldehyde 3-phosphate 
dehydrogenase were from Santa Cruz Bio-
technology (Santa Cruz, CA, USA). 3-Isobu-
tyl-1-methylxanthine (IBMX), dexame-
thasone, and insulin were obtained from 
Sigma (St. Louis, MO, USA). All chemicals 
and reagents used were of analytical grade 
and obtained from commercial sources.  
 
Preparation of velvet antler sample 
The velvet antler was kindly provided by 
the Daesungsan Deer Farm (Daegwallyeong, 
Korea). It was obtained from a farmed elk at 
75 days after casting. The fresh velvet antler 
was immediately sliced using a bone slicer 
and frozen at -20 °C. The frozen slices were 
dehydrated by lyophilization (freeze dryer; 
Ilshin Lab Co., Ltd, Gyeonggi, Korea) and 
then ground into a fine powder using a grinder 
(HMF-3100S; Hanil Co., Gyeongbukgong, 
Korea). 
 
Preparation of enzymatic hydrolysate from 
velvet antler  
Enzymatic hydrolysis of the velvet antler 
was performed according to a previously re-
ported method (Ko et al., 2013a). The ground 
dried velvet antler powder (6 g) was first ho-
mogenized with 600 mL of distilled water 
(pH 6.0), and 60 μL of Protamex (Novo 
Nordisk, Bagsvaerd, Denmark) was then 
added. Enzymatic hydrolysis was conducted 
at 40 °C for 24 h, after which the hydrolysate 
was boiled for 10 min at 100 °C to inactivate 
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the enzyme. The hydrolysate was clarified by 
centrifugation at 3000 × g for 20 min to re-
move any unhydrolyzed residue. The super-
natant of the velvet antler Protamex hydroly-
sate (VAPH) was filtered, adjusted to pH 7.0, 
and stored for subsequent use in experiments. 
 
Analysis of bioactive components 
The protein content was determined by 
using a commercial assay kit (BCA Protein 
Assay Kit; Thermo Fisher Scientific, Wal-
tham, MA, USA). The sulfated-glycosamino-
glycan (sulfated-GAG) content was deter-
mined by the dimethylmethylene blue (DMB) 
dye assay method (Farndale et al., 1982). In 
brief, the color reagent was prepared by dis-
solving 0.008 g of DMB in a solution contain-
ing 1.185 g of NaCl, 1.520 g of glycine, and 
0.47 mL of 12 M HCl dissolved in 500 mL of 
distilled water. Each sample was mixed with 
1 mL of this color reagent, and the absorbance 
was determined immediately at 525 nm using 
a spectrophotometer.  
The uronic acid content was determined 
from the carbazole reaction (Cesaretti et al., 
2003). A 50 μL aliquot of standard (carba-
zole) or samples was placed in a 96-well plate 
and supplemented with 200 μL of 25 mM so-
dium tetraborate solution in sulfuric acid. The 
plate was heated for 10 min at 100 °C in an 
oven. After cooling the plate at room temper-
ature for 15 min, 50 μL of 0.125 % carbazole 
dissolved in absolute ethanol was carefully 
added. Following a repeated round of heating 
at 100 °C for 10 min in the oven and cooling 
at room temperature for 15 min, the plate was 
read using a microtiter plate reader at a wave-
length of 550 nm.  
The sialic acid content was determined by 
the method of Warren (1959) with a slight 
modification. In brief, samples were hydro-
lyzed in 0.1 M H2SO4 in a final volume of 
1 mL for 1 h at 80 °C. Both the standard and 
samples were incubated respectively with 1 
mL of periodate solution at 37 °C for 30 min. 
Then, after the addition of 0.25 mL of 0.32 M 
sodium thiosulfate solution, the tubes were 
shaken until the characteristic yellow-brown 
color disappeared. The reaction was com-
pleted by the addition of 1.25 mL of 0.1 M 
thiobarbituric acid solution and the tubes were 
then subjected to a repeated cycle of heating 
to 100 °C for 15 min and cooling to room tem-
perature. The product was extracted with 
acidic butanol and the optical density was de-
termined at 549 nm.  
 
Cell culture and adipocyte differentiation 
3T3-L1 preadipocytes were cultured in 
DMEM containing 10 % BS and 1 % PS at 
37 °C under a 5 % CO2 atmosphere. To in-
duce differentiation, 2-day post-confluent 
preadipocytes (designated day 0) were cul-
tured in MDI differentiation medium (DMEM 
containing 1 % PS, 10 % FBS, 0.5 mM 
IBMX, 0.25 μM dexamethasone, and 
5 μg/mL insulin) for 2 days. The cells were 
then cultured for another 2 days in DMEM 
containing 1 % PS, 10 % FBS, and 5 μg/mL 
insulin. Thereafter, the cells were maintained 
in post-differentiation medium (DMEM con-
taining 1 % PS and 10 % FBS), with replace-
ment of the medium on every 2 days. To ex-
amine the effects of VAPH on the differenti-
ation of preadipocytes to adipocytes, the hy-
drolysate was added to cells cultured in MDI. 
Differentiation, as measured by the expres-
sion of adipogenic markers and the appear-
ance of lipid droplets, was completed on day 
8. The toxicity of VAPH to 3T3-L1 cells was 
evaluated by MTT assay. No significant toxic 
effect was observed on the cells treated with 
VAPH up to a concentration of 150 μg/mL 
(data not shown); therefore, VAPH amounts 
up to this concentration were chosen for the 
experiments.  
 
Determination of lipid accumulation by Oil 
Red O staining  
Cells were seeded in 6-well plates and ad-
ipocyte differentiation was induced for 8 days 
as described in Cell culture and adipocyte dif-
ferentiation section. On day 8, the cells were 
stained with Oil Red O (an indicator of cell 
lipid content) according to a previously de-
scribed method, with slight modifications 
(Ramirez-Zacarias et al., 1992). In brief, cells 
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were washed with phosphate-buffered saline 
(PBS), fixed with 10 % buffered formalin, 
and stained with Oil Red O solution (0.7 g in 
200 mL of isopropanol) for 1 h at room tem-
perature. Thereafter, the Oil Red O staining 
solution was removed and the plates were 
rinsed with distilled water and dried. Images 
of the stained lipid droplets were taken under 
a light microscope (Olympus D970; Olympus 
Optical Co., Tokyo, Japan). Finally, the dye 
retained in the cells was eluted with isopropa-
nol and quantified by measuring the optical 
absorbance at 520 nm. 
 
Measurement of triglyceride content  
Cellular triglyceride contents were deter-
mined using a commercial triglyceride color-
imetric assay kit (Cayman Chemical, Ann Ar-
bor, MI, USA) according to the manufac-
turer’s instructions. The cells were washed 
twice with PBS, scraped into a homogenizing 
solution, and sonicated to homogenize the cell 
suspension. The residual cell lysate was cen-
trifuged at 3000 × g for 5 min at 4 °C to re-
move the fat layer. The supernatants were an-
alyzed for the content of triglycerides and 
proteins. Triglycerides were normalized with 
the respective protein concentration, employ-
ing bovine serum albumin as the calibration 
standard. Results are represented as the 
amount of triglyceride in milligram to an 
equivalent of cellular proteins (in milligram). 
 
Western blot analysis 
Cell lysates were prepared using lysis 
buffer containing 20 mM Tris, 10 mM 
Na4P2O7, 5 mM ethylenediaminetetraacetic 
acid, 100 mM NaF, 2 mM Na3VO4, 10 mg/ 
mL aprotinin, 1 % NP-40, 1 mM phenylme-
thylsulfonyl fluoride, and 10 mg/mL leupep-
tin. Cellular debris was removed by centrifu-
gation at 10000 × g under 0 °C for 15 min. 
The protein concentrations were analyzed us-
ing the BCA Protein Assay Kit. The protein 
levels were normalized to 50 μg for the elec-
trophoresis on a sodium dodecyl sulfate poly-
acrylamide gel (SDS-PAGE). The separated 
protein bands were transferred onto a nitrocel-
lulose membrane. The nonspecific binding 
sites were blocked with 5 % non-fat dry milk 
in TBST (25 mM Tris-HCl, 2.65 mM KCl, 
137 mM NaCl, 0.05 %, Tween 20, pH 7.4). 
The primary antibodies were introduced at a 
1:1000 dilution, following overnight incuba-
tion at 4 °C. The membranes were gently 
rinsed using TBST and incubated with the re-
spective secondary antibodies at a 1:3000 di-
lution. An ECL Western blotting detection kit 
was used to develop the signals by exposing 
on to X-ray films.  
 
Animal experiment and study design  
C57BL/6 male mice, 5 weeks old and 
weighing 19–22 g, were purchased from 
Jung-Ang Lab Animal Inc. (Seoul, Korea). 
All mice were housed in a room with con-
trolled temperature (22 °C), humidity (55 %), 
and lighting (12 h light/dark cycle), and given 
water ad libitum. After acclimatization with a 
pelletized commercial diet for 1 week, all the 
experimental mice were divided randomly 
into four groups (n = 6/group): normal diet 
(ND), high-fat diet (HFD) control, 
HFD+VAPH100 (100 mg/kg of VAPH), and 
HFD+VAPH300 (300 mg/kg of VAPH). The 
ND group was fed a normal diet, whereas the 
HFD, HFD+VAPH100, and HFD+VAPH300 
groups were fed a diet high in fat [45 % (w/w) 
fat; Jung-Ang Lab Animal Inc]. All diets were 
fed ad libitum. The VAPH sample was dis-
solved in saline and administered orally to the 
HFD+VAPH100 and HFD+VAPH300 
groups, whereas saline was administered 
orally to the ND and HFD groups, for 13 
weeks. Body weights were measured once 
every week. After 13 weeks, the mice were 
anesthetized and blood and organs were col-
lected.  
 
Serum biochemical analysis 
All mice were fasted for 12 h before sac-
rifice. Blood was collected and centrifuged at 
3000 × g for 10 min at 4 °C to obtain the se-
rum. The total cholesterol (TC), high-density 
lipoprotein cholesterol (HDL-C), glucose, 
and triglyceride (TG) levels were determined 
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by enzymatic methods using commercial as-
say kits (Asan Pharm. Co., Ltd., Seoul, Ko-
rea).  
 
Histological analysis of liver and adipose 
tissues 
The epididymal adipose tissues and liver 
tissues were fixed in a buffer solution contain-
ing 10 % formalin and embedded in paraffin. 
Sections (3 μm thick) were peeled and 
mounted on glass slides. Xylene and alcohol 
were used to remove paraffin. Hematoxylin 
and eosin (H&E) were used to stain the sec-
tions. After alcohol dehydration, the photo-
graphs of the slides were taken by using a 
light microscope (Olympus D970; Olympus 
Optical Co.).  
 
Statistical analysis 
Data are expressed as mean ± SE. For the 
in vitro studies, differences between the con-
trol and treated groups were evaluated by Stu-
dent’s t-test. For in vivo studies, differences 
between the means of the individual groups 
were assessed by one-way analysis of vari-
ance with Duncan’s multiple-range tests. For 
all analyses, a probability value of p < 0.05 
was considered statistically significant. All 
statistical analyses were performed using 
SPSS software. 
 
RESULTS 
Main ingredients of VAPH 
The main ingredients of VAPH are shown 
in Table 1, where the total extraction yield 
was 35.33 %. The protein content was 
348.25 mg/g and was, therefore, higher than 
the concentrations of the other extractable 
components. The other main component was 
uronic acid (198.59 mg/g), whereas sulfated-
GAGs (33.13 mg/g) and sialic acid (5.55 mg/ 
g) were in minor amounts. These results sug-
gest that the protein of VAPH were major bi-
oactive hydrolysate. 
 
Effect of VAPH on intracellular lipid  
accumulation in adipocytes  
Anti-adipogenic effects of VAPH on the 
differentiation of preadipocyte into adipo-
cytes was examined by using 3T3-L1 preadi-
pocytes exposed to VAPH for 8 days (from 
days 0 to 8). Lipid accumulation was taken as 
a measurement of adipogenesis, and quanti-
fied at the end of the proposed differentiation 
period by assessing the triglyceride levels and 
Oil-Red-O staining. As shown in Figure 1A, 
VAPH significantly reduced the intracellular 
lipid accumulation in differentiated adipo-
cytes in a dose-dependent manner. Further-
more, VAPH significantly decreased the in-
tracellular triglyceride levels relative to that in 
untreated control cells at all VAPH concen-
trations tested (Figure 1B). These results indi-
cate that VAPH effectively blocks the for-
mation of mature 3T3-L1 adipocytes.  
 
 
Table 1: Contents of main ingredients of enzymatic hydrolysates from velvet antler  
Name Yield (%) Crude protein (mg/g) 
Sulfated-GAGs 
(mg/g) 
Sialic acid 
(mg/g) 
Uronic acid 
(mg/g) 
VAPH 35.33±1.33 348.25±6.1 33.13±2.31 5.55±0.08 198.59±8.62 
Each value is expressed as mean ± SE (n = 3). Sulfated-GAGs, sulfated-glycosaminoglycans; VAPH, velvet antler Protamex 
hydrolysate 
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Figure 1: (A) Intracellular lipid accumulation in 
3T3-L1 adipocytes after completion of the differ-
entiation process. Microscopic images of adipo-
cytes stained with Oil Red O, and quantification of 
the lipid accumulation in VAPH-treated and non-
treated (control) adipocytes after Oil Red O elu-
tion. (B) Effect of VAPH on triglyceride levels in 
3T3-L1 adipocytes. The values are expressed as 
milligram of triglyceride per milligram of cellular 
protein. Each value is expressed as mean ± SE (n 
= 3). The letters a and b indicate that the means 
are significantly different (p < 0.05). Scale bar, 50 
μm. VAPH, velvet antler Protamex hydrolysate. 
 
 
Effect of VAPH on the expression of  
adipogenic-specific proteins 
To elucidate the molecular mechanisms 
by which VAPH inhibits adipogenesis, its ef-
fect on the protein expression of the adipo-
genic transcription factors PPARγ, SREBP-1, 
and C/EBPα was investigated using Western 
blot analysis (Figure 2). As expected, the re-
sults showed that the presence of VAPH sig-
nificantly reduced the protein expression lev-
els of these three transcription factors, espe-
cially that of PPARγ (Figure 2). These data 
suggest that VAPH results in the down-regu-
lated expression of adipogenesis transcription 
factors, with the subsequent inhibition of adi-
pocyte differentiation.  
 
Effect of VAPH on HFD-induced obesity in 
vivo 
The effect of VAPH on obesity was inves-
tigated using HFD-fed C57BL/6 male mice. 
The body weight changes during the experi-
ment are shown in Figure 3A. During the 
study duration spanning 13-weeks, the mice 
in the HFD group indicated increased body 
weight significantly from the starting weight, 
compared to the ND group. Yet, the body 
weights of HFD+VAPH100 and 
HFD+VAPH300 groups were lower relative 
to the HFD group. After the 9th week, a sig-
nificant difference between the body weight 
of the HFD and HFD+VAPH groups were ob-
served upon VAPH treatment. By the end of 
the experimental period, the body weight gain 
in VAPH-treated groups significantly attenu-
ated in comparison to the HFD group (Figure 
3B). 
 
Effect of VAPH on serum biochemical  
levels  
The serum biochemical levels are shown 
in Figure 4. For 13 weeks, the serum glucose 
and TG levels were significantly higher in the 
HFD group than in the ND group. However, 
the TG levels were significantly lower in both 
VAPH-treated groups than in the HFD group 
(Figure 4B). Furthermore, the glucose levels 
of the HFD+VAPH300-treated mice were 
significantly lower than those of the HFD-
treated mice (Figure 4A). The TC levels were 
significantly increased in the HFD group, 
compared with the ND group. However, no 
significant difference was observed between 
the HFD and HFD+VAPH groups (Figure 
4C). Although the HDL-C levels were not sig-
nificantly different between the HFD and ND 
groups, the HFD+VAPH groups had signifi-
cantly higher levels than the HFD group (Fig-
ure 4D). 
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Figure 2: Effect of VAPH on SREBP-1, PPARγ, and C/EBPα expression in 3T3-L1 adipocytes, as ex-
amined by Western blot analysis. Each value is expressed as mean ± SE (n = 3). The letters a, b, and 
c indicate that the means are significantly different (p < 0.05). C/EBPα, CCAAT/enhancer binding protein 
alpha; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; PPARγ, peroxisome proliferator activated 
receptor gamma; SREBP-1, sterol regulatory element binding protein 1; VAPH, velvet antler Protamex 
hydrolysate 
 
 
Figure 3: Effects of VAPH supplementation on 
changes in body weight (A) and body weight gain 
(B) in HFD-fed obese mice. The values are ex-
pressed as mean ± SE (n = 6). ##p < 0.005 com-
pared with the ND group, *p < 0.05 compared with 
the HFD group. ND, normal diet; HFD, high-fat 
diet-fed control; HFD+VAPH100, HFD and 100 
mg/kg of velvet antler Protamex hydrolysate; 
HFD+VAPH300, HFD and 300 mg/kg of velvet 
antler Protamex hydrolysate 
Effect of VAPH on histopathological 
changes in obese mice liver and adipose  
tissues 
H&E stains were used to stain adipose and 
liver tissues for the histochemical observa-
tion. The HFD group (Figure 5A, panel b) in-
dicated a substantial accumulation of hepatic 
lipid droplets, compared to the ND group 
(Figure 5A, panel a), whereas it indicated a 
reduced accumulation in groups that received 
VAPH treatment (Figure 5A, panels c and d). 
In particular, droplet accumulation in the 
HFD+VAPH300 group was almost com-
pletely reduced to that of the ND group level. 
As shown in Figure 5B, the size of adipocytes 
in epididymal tissue was much larger in the 
HFD group (panel b) than in the ND group 
(panel a). However, the size of adipocytes in 
the VAPH-treated groups was dramatically 
smaller than that of the HFD group (panels c 
and d). These results show that VAPH effi-
ciently prevents fat accumulation in the liver 
and the increase in adipocyte size.  
A 
B 
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Figure 4: Effects of VAPH supplementation on serum glucose (A), triglyceride (B), total cholesterol (C) 
and high-density lipoprotein cholesterol (D) levels in HFD-induced obese mice. The values are ex-
pressed as mean ± SE (n = 6). ##p < 0.005 compared with the ND group, *p < 0.05 compared with the 
HFD group, and **p < 0.005 compared with the HFD group. ND, normal diet; HFD, high-fat diet-fed 
control; HFD+VAPH100, HFD and 100 mg/kg of velvet antler Protamex hydrolysate; HFD+VAPH300, 
HFD and 300 mg/kg of velvet antler Protamex hydrolysate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Histopathological changes in liver 
and adipose tissues. (A) Accumulation of lipid 
droplets in liver tissue. (B) Changes in the size 
of adipocytes in epididymal white adipose tis-
sue. Mice were assigned to one of four groups 
(a: normal diet group; b: high-fat diet-fed 
(HFD) group; c: HFD plus 100 mg/kg body 
weight (BW) of velvet antler Protamex hydrol-
ysate (VAPH) group; and d: HFD plus 300 mg/ 
kg BW of VAPH group) and treated for 13 
weeks. The mice were sacrificed and liver and 
white adipose tissue samples were obtained, 
fixed, and sliced. The sections were stained 
with hematoxylin and eosin and examined un-
der a light microscope (125× magnification). 
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DISCUSSION 
Velvet antler is a typical traditional ani-
mal medicine that has been used for over 2000 
years. It has been used in traditional Korean 
and Chinese medicines to prevent and treat 
many human diseases (Sui et al., 2014; Lee et 
al., 2015). However, the anti-obesity effect of 
velvet antler has not been studied. Obesity is 
a major health issue throughout the globe and 
an issue with increased concern in the 21st 
century (Omoleke, 2011). It is associated with 
the progression of metabolic disease condi-
tions such as type 2 diabetes, hypertension 
and cardiovascular disorders (Xavier and 
Sunyer, 2002; Lee et al., 2005; Kong et al., 
2009). Many recent studies report anti-obesity 
agents from natural products (Kong et al., 
2009; Popovich et al., 2010; Ko et al., 2013b; 
Mohamed et al., 2014), and interest in explor-
ing the applications of medicinally beneficial 
products has increased (Kessler et al., 2001). 
However, reports that document the anti-obe-
sity activity of health foods containing unique 
animal ingredients are still relatively rare. 
Therefore, this study is the first to investigate 
the anti-obesity effect of an enzymatic hydrol-
ysate from velvet antler in vitro and in vivo, 
using 3T3- L1 cells and mice fed a high-fat 
diet, respectively.  
The traditional extraction of bioactive 
components from velvet antler is generally 
done via simmering in hot water. However, 
there is some controversy surrounding this ap-
proach, due largely to the extremely limited 
recovery of water-soluble components in wa-
ter extractions. During the last decade, en-
zyme-assistant extraction has successfully 
been applied for the successful extraction of 
numerous biologically active natural products 
from a wide variety of organisms. This tech-
nique results in higher yields of bioactive 
compounds that also show enhanced biologi-
cal activity compared with ingredients ex-
tracted by water or organic solvents employ-
ing harsh conditions (Lee et al., 2012; Puri et 
al., 2012; Ko et al., 2013a; Lee et al., 2015). 
Therefore, in the present study, the velvet ant-
ler was enzymatically hydrolyzed using the 
commercial protease Protamex to make it ac-
ceptable as a health food and nutraceutical. It 
has been reported that velvet antlers are rich 
in polypeptides and proteins, which are con-
sidered to be the most prominent bioactive 
components (Sui et al., 2014). In this study, 
the protein content in VAPH was higher than 
that of the other extractable components. 
VAPH also contained a significant quantity of 
uronic acid, along with minor amounts of sul-
fated-GAGs and sialic acid. These results 
suggest that the main ingredients of VAPH 
are protein and uronic acid (an acidic polysac-
charide). The sialic acid content of the VAPH 
obtained in this study was similar to that ob-
served by Je et al. (2010), who used hot water 
extracts. However, the sulfated-GAG and 
uronic acid contents in VAPH were higher 
than those from the hot water extracts. Taken 
together, these data indicate that enzymatic 
extraction techniques for obtaining the bioac-
tive components of velvet antler may be more 
advantageous than hot water extraction. 
Possible mechanisms for reducing obesity 
include decreasing the energy or food intake, 
increasing energy expenditure, and inhibiting 
preadipocyte differentiation, lipogenesis, and 
proliferation (Wang and Jones, 2004). Differ-
entiation of preadipocyte into mature adipo-
cytes and accumulation of fat play key roles 
in the pathogenesis of obesity (Jeon et al., 
2004). In this study, the effect of VAPH on 
preadipocyte differentiation was investigated 
by measuring lipid accumulation as well as 
the expression of several adipogenesis-related 
proteins in differentiated 3T3-L1 cells. VAPH 
treatment dose dependently reduced the tri-
glyceride levels along with the absorbance 
values of Oil Red O solution leached into the 
cytoplasm of treated cells, suggesting that the 
function of hydrolysate proceeds by inhibit-
ing adipogenesis through reducing lipid accu-
mulation. The present study is the first to 
demonstrate the effectiveness of VAPH in 
this respect.  
Adipogenesis is induced through the ac-
tion of adipogenic transcription factors such 
as PPARγ, SREBP-1, and C/EBPα (White 
and Stephens, 2010), which are regulated in 
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the early stage of adipocyte differentiation 
(Latasa et al., 2000; Luong et al., 2000). 
Therefore, overexpression of these transcrip-
tion factors can accelerate adipogenesis. To 
evaluate whether VAPH possesses the ability 
to inhibit adipocyte differentiation through 
PPARγ, SREBP-1, and C/EBPα, the expres-
sion of these proteins was measured using 
Western blot analysis. The PPARγ, SREBP-
1, and C/EBPα expression levels were down-
regulated in the presence of VAPH compared 
with control adipocytes, suggesting that the 
hydrolysate may indeed inhibit lipid accumu-
lation by blocking the expression of these 
transcription factors. 
Although the causes of obesity are com-
plex, the dietary element, especially a diet 
containing excessive fat, is a known risk fac-
tor. Because animals fed a HFD are consid-
ered to be suitable models for obesity studies 
(Kang et al., 2012), we used mice fed a HFD 
to examine the anti-obesity effects of VAPH 
in vivo. Mice fed a HFD gained significantly 
more weight than those fed a normal diet, 
confirming that the diet-induced obesity was 
successful. However, interestingly, the body 
weight gain decreased significantly in the 
HFD+VAPH-treated groups compared with 
mice fed only a HFD. This supported the re-
sults of our in vitro study, in that VAPH has 
an anti-adipogenic effect on preadipocyte dif-
ferentiation.  
Excessive fat accumulation and weight 
gain lead to hyperlipidemia and other meta-
bolic disorders related to obesity (Hollie and 
Hui, 2011). In the present study, the HFD 
group exhibited significantly higher levels of 
serum TG, glucose, and TC than the ND 
group, as expected. However, the HFD 
groups treated with VAPH demonstrated re-
versal of the hyperlipidemic blood status, 
showing decreased serum TG and glucose 
contents and increased serum HDL-C levels. 
Previous studies have reported on the effec-
tiveness of velvet antler water-soluble ex-
tracts in decreasing the TG levels and increas-
ing the HDL-C levels in rats (Cui et al., 2008), 
which are similar to our results obtained with 
VAPH on mice. 
We also found that the 13-week VAPH 
treatment of obese mice resulted in markedly 
decreased hepatic accumulation of lipid drop-
lets compared with the non-treated obese 
mice. This suggests that VAPH might im-
prove non-alcoholic fatty liver disease associ-
ated with obesity. Likewise, reduced lipid ac-
cumulation was seen in the epididymal white 
adipose tissue of VAPH-treated obese mice 
relative to the untreated HFD group.  
 The current study had certain limitations 
mainly the relatively short-term evaluation 
that spans 13 weeks may not be appropriate in 
predicting long-term effects of VAPH. Alt-
hough the current study demonstrates the anti-
obesity effect of VAPH, the bioactive compo-
nent/s responsible for the observed effects re-
mains vague. Some of the bioactive peptides 
obtained from bioactive hydrolysate contain-
ing large amounts of protein have been re-
ported to show anti-adipogenic effects in cell 
lines (Kim et al., 2007; Delattre et al., 2012; 
Singh et al., 2014). As VAPH contains a high 
amount of protein, further studies will be 
needed to identify them as the bioactive pep-
tides in the hydrolysate.  
 In conclusion, these results are the first to 
demonstrate an inhibitory effect of VAPH on 
adipogenesis. In addition, VAPH could bene-
ficially reduce the body weight gain and im-
prove the lipid profile in mice fed a high-fat 
diet. Therefore, we suggest that VAPH may 
be a promising candidate for preventing obe-
sity or obesity-related diseases.  
 
Acknowledgements 
This research was supported by Basic Sci-
ence Research Program through the National 
Research foundation of Korea (NRF) funded 
by the Ministry of Education (NRF-
2014R1A1A2056551). 
 
Conflict of interest 
The authors declare that they have no con-
flict of interest. 
EXCLI Journal 2017;16:328-339 – ISSN 1611-2156 
Received: September 12, 2016, accepted: March 02, 2017, published: March 22, 2017 
 
 
338 
REFERENCES 
Cesaretti M, Luppi E, Maccari F, Volpi N. A 96-well 
assay for uronic acid carbazole reaction. Carbohydr 
Polym. 2003;54:59-61.  
Chen D, Yao WJ, Zhang XL, Han XQ, Qu XY, Ka 
WB, ert al. Effects of Gekko sulfated polysaccharide-
protein complex on human hepatoma SMMC-7721 
cells: inhibition of proliferation and migration. J Eth-
nopharmacol. 2010;127:702-8.  
Cui XS, Kim HI, Cho SK. Effect of water soluble ex-
tracts from velvet antler on lipid metabolism and blood 
components in rats. J Anim Sci Technol. 2008;50:417-
28.  
Delattre C, Chaisemartin L, Favre-Mercuret M, 
Berthon JY, Rios L. Biological effect of β-(1,3)-poly-
glucuronic acid sodium salt on lipid storage and adipo-
cytes differentiation. Carbohydr Polym. 2012;87:775-
83.  
Farndale RW, Sayers CA, Barrett AJ. A direct spectro-
photometric microassay for sulfated glycosaminogly-
cans in cartilage cultures. Connect Tissue Res. 1982;9: 
247-8.  
Ge G, Yu C, Yu B, Shen Z, Zhang D, Wu Q. Antitumor 
effects and chemical compositions of Eupolyphaga 
sinensis Walker ethanol extract. J Ethnobiol. 2012;141: 
178-82.  
Gilbey A, Perezgonzalez JD. Health benefits of deer 
and elk velvet antler supplements: a systematic review 
of randomised controlled studies. N Z Med J. 2012; 
125:80-6.  
Hollie NI, Hui DY. Group 1B phospholipase A2 defi-
ciency protects against diet-induced hyperlipidemia in 
mice. J Lipid Res. 2011;52:2005-11.  
Je JY, Park PJ, Kim EJ, Kim HA, Lim DH, Jeon BT, et 
al. Composition of biologically active substances and 
antioxidant activity of New Zealand deer velvet antler 
extracts. Korean J Food Sci Anim Resour. 2010;30:20-
7.  
Jeon T, Hwang SG, Hirai S, Matsui T, Yano H, Ka-
wada T, et al. Red yeast rice extracts suppress adipo-
genesis by down-regulating adipogenic transcription 
factors and gene expression in 3T3-L1 cells. Life Sci. 
2004;75:3195-203.  
Kang YR, Lee HY, Kim JH, Moon DI, Seo MY, Park 
SH, et al. Anti-obesity and anti-diabetic effects of 
Yerba Mate (Ilex paraguariensis) in C57BL/6 J mice 
fed a high-fat diet. Lab Anim Res. 2012;28:23-9. 
Kawtikwar PS, Bhagwat DA, Sakarkar DM. Deer ant-
lers - traditional use and future perspectives. Indian J 
Tradit Knowl. 2010;9:245-51. 
Kessler RC, Davis RB, Foster DF, Van Rompay MI, 
Walters EE, Wilkey SA, et al. Long-term trends in the 
use of complementary and alternative medical thera-
pies in the United States. Ann Intern Med. 2001;135: 
262-8.  
Kim CT, Gujral N, Ganguly A, Suh JW, Sunwoo HH. 
Chondroitin sulphate extracted from antler cartilage 
using high hydrostatic pressure and enzymatic hydrol-
ysis. Biotechnol Rep. 2014;4:14-20.  
Kim HJ, Bae IY, Ahn CW, Lee S, Lee HG. Purification 
and identification of adipogenesis inhibitory peptide 
from black soybean protein hydrolysate. Peptides. 
2007;28:2098-103.  
Ko JY, Lee JH, Samarakoon K, Kim JS, Jeon YJ. Pu-
rification and determination of two novel antioxidant 
peptides from flounder fish (Paralichthys olivaceus) 
using digestive proteases. Food Chem Toxicol. 2013a; 
52:113-20.  
Ko SC, Lee M, Lee JH, Lee SH, Lim Y, Jeon YJ. 
Dieckol, a phlorotannin isolated from a brown sea-
weed, Ecklonia cava, inhibits adipogenesis through 
AMP-activated protein kinase (AMPK) activation in 
3T3-L1 preadipocytes. Environ Toxicol Pharmacol. 
2013b:36:1253-60.  
Kong CS, Kim JA, Kim SK. Anti-obesity effect of sul-
fated glucosamine by AMPK signal pathway in 3T3-
L1 adipocytes. Food Chem Toxicol. 2009;47:2401-6.  
Latasa MJ, Moon YS, Kim KH, Sul HS. Nutritional 
regulation of the fatty acid synthase promoter in vivo: 
sterol regulatory element binding protein functions 
through an upstream region containing a sterol regula-
tory element. Proc Natl Acad Sci. 2000;97:10619-24.  
Lee SH, Park MH, Park SJ, Kim J, Kim YT, Oh MC, 
et al. Bioactive compounds extracted from Ecklonia 
cava by using enzymatic hydrolysis protects high glu-
cose-induced damage in INS-1 pancreatic β-cells. Appl 
Biochem Biotechnol. 2012;167:1973-85.  
Lee SH, Yang HW, Ding Y, Wang Y, Jeon YJ, Moon 
SH, et al. Anti-inflammatory effects of enzymatic hy-
drolysates of velvet antler in Raw 264.7 cells in vitro 
and zebrafish model. EXCLI J. 2015;14:1122-32.  
Lee WJ, Koh EH, Won JC, Kim MS, Park JY, Lee KU. 
Obesity: the role of hypothalamic AMP-activated pro-
tein kinase in body weight regulation. Int J Biochem 
Cell B. 2005;37:2254-9.  
EXCLI Journal 2017;16:328-339 – ISSN 1611-2156 
Received: September 12, 2016, accepted: March 02, 2017, published: March 22, 2017 
 
 
339 
Luong A, Hannah VC, Brown MS, Goldstein JL. Mo-
lecular characterization of human Acetyl-CoA Synthe-
tase, an enzyme regulated by sterol regulatory element-
binding proteins. J Biol Chem. 2000;275:26458-66.  
Mohamed GA, Ibrahim SR, Elkhayat ES, Ei Dine RS. 
Natural anti-obesity agents. Bull Fac Pharm Cairo 
Univ. 2014;52:269-84.  
Omoleke SA. Obesity: A major public health challenge 
of 21st century in the United Kingdom (UK). J Public 
Health Epidemiol. 2011;3:560-6. 
Popovich DG, Li L, Zhang W. Bitter melon (Momor-
dica charantia) triterpenoid extract reduces preadipo-
cyte viability, lipid accumulation and adiponectin ex-
pression in 3T3-L1 cells. Food Chem Toxicol. 2010; 
48:1619-26.  
Puri M, Sharma D, Barrow CJ. Enzyme-assisted ex-
traction of bioactives from plants. Trends Biotechnol. 
2012;30:37-44. 
Ramirez-Zacarias JL, Castro-Mufiozledo F, Kuri-Har-
cuch W. Quantitation of adipose conversion and tri-
glycerides by staining intracytoplasmic lipids with oil 
red O. Histochemistry. 1992;97:493-7. 
Singh PB, Vij S, Hati S. Functional significance of bi-
oactive peptides derived from soybean. Peptides. 2014; 
54:171-9.  
Sui Z, Zhang L, Huo Y, Zhang Y. Bioactive compo-
nents of velvet antlers and their pharmacological prop-
erties. J Pharm Biomed Anal. 2014;87:229-40.  
Warren L. The thiobarbituric acid assay of sialic acids. 
J Biol Chem. 1959;234:1971-5.  
Wang YW, Jones PJ. Conjugated linoleic acid and obe-
sity control: efficacy and mechanisms. Int J Obes. 
2004;28:941-55. 
White UA, Stephens JM. Transcriptional factors that 
promote formation of white adipose tissue. Mol Cell 
Endocrinol. 2010;318:10-4.  
Xavier F, Sunyer P. The obesity epidemic: pathophys-
iology and consequences of obesity. Obes Res. 2002; 
10:97S-104S. 
